Home » Topics » Articles » Insight

Insight
RSS

Public Financing Of Biotechnology: September 1999

Oct. 4, 1999

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: August 1999

Sep. 27, 1999

Photodynamic Firms See Light At End Of The Tunnel

Sep. 27, 1999

FDA Submissions, Approvals And Other Actions: August 1999

Sep. 27, 1999

Clinical Trial Update: August 1999

Sep. 20, 1999

Biotech Companies Rarely Use Tracking Stock Option

Sep. 20, 1999

Private Financings Remain Surest Way To Raise Money

Sep. 13, 1999

Public Financing Of Biotechnology: August 1999

Sep. 13, 1999

Other Financings Of Public Biotechnology Companies: August 1999

Sep. 13, 1999

Venture Capital, PIPE/Reg. S And Corporate Investments In Biotechnology Companies: August 1999

Sep. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...